Zonulo-hyaloido-vitrectomy for Malignant Glaucoma

Malignant Glaucoma Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02613143
• Other study ID #: DXX-WZ
• Status: Recruiting
• Phase: N/A
• First received: November 16, 2015
• Last updated: November 20, 2015

Study information

• Verified date: November 2015
• Source: Wenzhou Medical University
• Contact: Xixia Ding, Ph.D
• Phone: +86 13780148109
• Email: dingxixiaxc[@]163.com
• Is FDA regulated: No
• Health authority: China: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess the zonulo-hyaloido-vitrectomy for malignant glaucoma through an anterior approach.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patients who underwent the zonulo-hyaloido-vitrectomy for malignant glaucoma through an anterior approach

Exclusion Criteria:

• systemic disease or inflammation

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Glaucoma
• Malignant Glaucoma

Locations

Country	Name	City	State
China	Wenzhou Medical University	Wenzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Wenzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	intraocular pressure	The intraocular pressure is measured by the non-contact tonometer.	3 years